Literature DB >> 8665475

Activation of the complement system by pathogenic fungi.

T R Kozel1.   

Abstract

Fungi have been studied as prototype activators of the complement cascade since the early 1900s. More recently, attention has focused on the role of the complement system in the pathogenesis of fungal infections. The interactions of Cryptococcus neoformans and Candida albicans with the complement system are the most widely characterized; however, all pathogenic fungi examined to date have the ability to initiate the complement cascade. The molecular mechanisms for initiation and regulation of the complement cascade differ from one fungus to another, most likely reflecting differences in the structure of the outer layers of the cell wall. The molecular bases for such differences remain to be identified. Studies of mycoses in experimental animals with induced or congenital deficiencies in the complement system demonstrate that complement is an important innate system for control of fungal infection. Contributions to host resistance include opsonization and generation of inflammatory mediators. Inflammation induced by chemotactic products of the complement system may contribute to the pathogenesis of some fungal infections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8665475      PMCID: PMC172880          DOI: 10.1128/CMR.9.1.34

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  102 in total

1.  Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces.

Authors:  S K Law; N A Lichtenberg; R P Levine
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

2.  Alternative pathway of complement activation by Candida albicans.

Authors:  Y H Thong; A Ferrante
Journal:  Aust N Z J Med       Date:  1978-12

3.  Chemotaxigenic activity of extracts from the mycelial and spherule phases of Coccidioides immitis for human polymorphonuclear leukocytes.

Authors:  J N Galgiani; R A Isenberg; D A Stevens
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

4.  Complement activation by Coccidioides immitis: in vitro and clinical studies.

Authors:  J N Galgiani; P Yam; L D Petz; P L Williams; D A Stevens
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

5.  Role of complement in host defense against experimental disseminated candidiasis.

Authors:  J A Gelfand; D L Hurley; A S Fauci; M M Frank
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

6.  Location of mannan and chitin on thin sections of budding yeasts with gold markers.

Authors:  M Horisberger; M Vonlanthen
Journal:  Arch Microbiol       Date:  1977-10-24       Impact factor: 2.552

7.  Protective murine monoclonal antibodies to Cryptococcus neoformans.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Activation of the alternative complement pathway by Histoplasma capsulatum.

Authors:  W D Ratnoff; J M Pepple; J A Winkelstein
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

9.  Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans.

Authors:  K A Laxalt; T R Kozel
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

10.  Comparison by ELISA of serum anti-Candida albicans mannan IgG levels of a normal population and in diseased patients.

Authors:  P F Lehmann; E Reiss
Journal:  Mycopathologia       Date:  1980-03-17       Impact factor: 2.574

View more
  40 in total

1.  Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae.

Authors:  J E Wang; A Warris; E A Ellingsen; P F Jørgensen; T H Flo; T Espevik; R Solberg; P E Verweij; A O Aasen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Characterization of a flocculation-like phenotype in Cryptococcus neoformans and its effects on pathogenesis.

Authors:  Li Li; Oscar Zaragoza; Arturo Casadevall; Bettina C Fries
Journal:  Cell Microbiol       Date:  2006-06-07       Impact factor: 3.715

3.  Interactions of Penicillium marneffei with human leukocytes in vitro.

Authors:  Y Rongrungruang; S M Levitz
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis.

Authors:  U Vogel; A Weinberger; R Frank; A Müller; J Köhl; J P Atkinson; M Frosch
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

5.  Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.

Authors:  C Retini; T R Kozel; D Pietrella; C Monari; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 6.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

7.  The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein.

Authors:  T Meri; A M Blom; A Hartmann; D Lenk; S Meri; P F Zipfel
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

8.  Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain.

Authors:  Alaka Mullick; Miria Elias; Serge Picard; Lucie Bourget; Orce Jovcevski; Susan Gauthier; Ashleigh Tuite; Penelope Harakidas; Craig Bihun; Bernard Massie; Philippe Gros
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.

Authors:  A Casadevall; W Cleare; M Feldmesser; A Glatman-Freedman; D L Goldman; T R Kozel; N Lendvai; J Mukherjee; L A Pirofski; J Rivera; A L Rosas; M D Scharff; P Valadon; K Westin; Z Zhong
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

10.  App1: an antiphagocytic protein that binds to complement receptors 3 and 2.

Authors:  Paola Stano; Virginia Williams; Maristella Villani; Eugene S Cymbalyuk; Asfia Qureshi; Yuxiang Huang; Giulia Morace; Chiara Luberto; Stephen Tomlinson; Maurizio Del Poeta
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.